Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients
MSDANCE
Effect of Dance Classes on Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis Patients
1 other identifier
interventional
29
1 country
1
Brief Summary
The evidence suggests that multiple sclerosis (MS) induces a decline in motor and cognitive function and provokes a shift in gut microbiome composition in patients. Therefore, the purpose of this study is to explore the effect of a 12-week dance class training program on the gut microbiota composition, motor function, and cognitive function of patients with MS. The investigators will also study the following:
- The impact of organised physical activity on quality of life
- The impact of organised physical activity on body composition and metabolic parameters (e.g., insulin sensitivity, lipid profile, ect.)
- The impact of organised physical activity on physical fitness (e.g., VO2max, Power, ect.)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedFirst Submitted
Initial submission to the registry
January 9, 2024
CompletedFirst Posted
Study publicly available on registry
January 24, 2024
CompletedJanuary 24, 2024
January 1, 2024
1.5 years
January 9, 2024
January 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The shift in the mean gut microbiota diversity
Influence of the interventions on the Shannon index. The higher the index, the more diverse the species are in the habitat. The value of the Shannon-Weaver diversity index usually ranges from 1.5 to 3.5 and only rarely exceeds 4.5.
Change from baseline at 3 months
Change from baseline in the mean quantitative mobility and leg function performance
Influence of the interventions on a time in 25-Foot Walk. The longer the duration, the worse the outcome. Normal values: less than 4 seconds; Mild impairment: 4-5.99 seconds; Moderate impairment: 6-9.99 seconds; Severe impairment: 10 seconds or more.
Change from baseline at 3 months
Change from baseline in the mean quantitative upper extremity function performance
Influence of the interventions on a 9-hole Peg Test. The longer the duration, the worse the outcome. Values: 0 (completed without any delays) or more.
Change from baseline at 3 months
Differences in the mean quantitative maximal oxygen consumption
Comparison of maximal oxygen consumption (VO2max) within groups (MS pre-intervention vs. post-intervention) and between groups (healthy subjects vs. MS pre- and post-intervention). The higher the values, the better the outcome. The general ranges for VO2max in healthy adults are: Average Values: Men: 35-40 ml/kg/min, and Women: 27-31 ml/kg/min; Good Fitness Level: Men: 45-50 ml/kg/min and Women: 38-42 ml/kg/min; Excellent Fitness Level: Men: 55-60 ml/kg/min or higher, and Women: 47-52 ml/kg/min or higher.
Changes from baseline at 3 months
Study Arms (3)
Dance
EXPERIMENTALThe patients persuading dance classes two times a wek for 3 months .
Passive
NO INTERVENTIONThe patients engage in no structured or self-induced physical exercise or activity (sedentary individuals)
Healthy subjects
NO INTERVENTIONThe subjects engage in sports recreationally
Interventions
Eligibility Criteria
You may qualify if:
- patients with multiple sclerosis, diagnosed according to official diagnostic criteria according to McDonald 2010
- Consent ability and written consent
- The expanded disability status scale (EDSS) \<5.5
- age 30 - 50
You may not qualify if:
- serious comorbidities including psychiatric diseases
- Significant cognitive impairment, clinically relevant or progressive disease (e.g., liver, kidney, cardiovascular system, respiratory tract, vascular system, brain, metabolism, thyroid) that could affect the course of the study
- Clinically relevant addiction or substance abuse disorder (defined as alcohol, drug and drug abuse)
- Nicotine consumption of \> 5 cigarettes per day and no willingness to stop consumption during therapeutic fasting.
- Malignant disease
- Insufficient mental possibility of cooperation Eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Biological and Medical Science, Faculty of Physical Education and Sport, Comenius University
Bratislava, 814 69, Slovakia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Viktor Bielik, prof.
Faculty of Physical Education and Sport, Comenius University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- prof.
Study Record Dates
First Submitted
January 9, 2024
First Posted
January 24, 2024
Study Start
March 1, 2022
Primary Completion
August 30, 2023
Study Completion
December 15, 2023
Last Updated
January 24, 2024
Record last verified: 2024-01